Proteins

Items 51-60 of 170

per page
Set Descending Direction
  1. Fc (human):FLT3 Ligand (human) (rec.)
    AG-40B-0119
    AG-40B-0119-C01010 µg
    CHF 240.00
    AG-40B-0119-30103 x 10 µg
    CHF 480.00
    AG-40B-0119-C100100 µg
    CHF 960.00
    Influence of FLT3L treatment on lymphocyte subpopulations. Method: C57BL/6 mice were injected intraperitoneally with 10 μg daily or were left untreated. (A) Percentages of indicated splenic subpopulations in FLT3L KO, WT control or WT-treated mice.
  2. Fc (human):FNDC4 (rec.)
    AG-40B-0213
    AG-40B-0213-C05050 µg
    CHF 330.00
    AG-40B-0213-30503 x 50 µg
    CHF 660.00
  3. Fc (human):RANKL, Soluble (mouse) (rec.)
    AG-40B-0059
    AG-40B-0059-C01010 µg
    CHF 265.00
  4. Fc (LAEA-PG)-KIH (mouse) IgG2b Control (rec.)
    AG-35B-0019
    AG-35B-0019-C05050 µg
    CHF 340.00
    NEW Fc (LAEA-PG)-KIH (mouse) IgG2b Control (rec.)
  5. Fc (LALA-PG)-KIH (human) IgG1 Control (rec.)
    AG-35B-0018
    AG-35B-0018-C05050 µg
    CHF 340.00
    Fc (LALA-PG)-KIH (human) IgG1 Control (rec.)
  6. Fc (LALA-PG)-KIH (human):GDF15 (human) (rec.)
    AG-40B-0253
    AG-40B-0253-C05050 µg
    CHF 440.00
    NEW Fc (LALA-PG)-KIH (human):GDF15 (human) (rec.)
  7. Fc (LALA-PG)-KIH (human):GDF15 (mouse) (rec.)
    AG-40B-0245
    AG-40B-0245-C05050 µg
    CHF 440.00
    Fc (LALA-PG)-KIH (human):GDF15 (mouse) (rec.)
  8. Fc (LALA-PG)-KIH (human):Irisin (monomeric) (rec.)
    AG-40B-0246
    AG-40B-0246-C05050 µg
    CHF 440.00

    Replaces AG-40B-0115

    Fc (LALA-PG)-KIH (human):Irisin (monomeric) (rec.)
  9. Fc (mouse) IgG2a Control (rec.) (non-lytic)
    AG-35B-0017
    AG-35B-0017-C01010 µg
    CHF 340.00
    AG-35B-0017-30103 x 10 µg
    CHF 680.00
    AG-35B-0017-C100100 µg
    CHF 1'360.00
    Fc (mouse) IgG2a Control (rec.) (non-lytic)

Items 51-60 of 170

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.